Key facts
- This page summarizes Jiaqiang Li's Form 3 filing for SINOVAC BIOTECH LTD (SVA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 17 Apr 2026, 06:10.
Jiaqiang Li - 17 Apr 2026 Form 3 Insider Report for SINOVAC BIOTECH LTD (SVA)
- Reporting relationship
- Director
- Issuer ticker
- SVA
- Reported as of
- 17 Apr 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Jiaqiang Li
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Jiaqiang Li filed Form 3 for SINOVAC BIOTECH LTD (SVA) on 17 Apr 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002126217
Primary reporting owner
Li Jiaqiang
- Relationship
- Director
- Address
- ONE INTERNATIONAL PL, 44TH FLOOR, BOSTON
- Signature
- /s/ Jiaqiang Li
- Signature date
- 17 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SVA
holding
Common shares, par value $0.001 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,515,315
- Date
- 17 Apr 2026
- Ownership
- By 1Globe Capital LLC, CDH Utopia Limited and the others
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represented (i) 6,812,855 Common shares, par value $0.001 per share, of the Issuer (the "Common Shares") held directly by 1Globe Capital LLC; (ii) 6,000,000 Common Shares held by CDH Utopia Limited (the "Subject Shares"), (x) over 70% of which 1Globe Biomedical (Hong Kong) Company Limited posseses the voting rights and (y) over all the which 1Globe Biomedical (Hong Kong) Company Limited posseses the voting rights over certain financial upside; and (iii) 5,702,460 Common Shares held by relatives or related parties of the Reporting Person.
Footnote F2
1Globe Biomedical (Hong Kong) Company Limited is the sole member of 1Globe Capital LLC and may be deemed to beneficially own the Common Shares held by 1Globe Capital LLC. 1Globe Biomedical (Hong Kong) Company Limited may be deemed to beneficially own the Subject Shares held by CDH Utopia Limited. The Reporting Person is the Chairman of each of 1Globe Capital LLC and 1Globe Biomedical (Hong Kong) Company Limited. The Reporting Person may be deemed the ultimate beneficial owner of the Common Shares held by 1Globe Capital LLC, 1Globe Biomedical (Hong Kong) Company Limited and his relatives.
Footnote F3
The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.